全文获取类型
收费全文 | 15957篇 |
免费 | 1650篇 |
国内免费 | 2013篇 |
专业分类
19620篇 |
出版年
2024年 | 69篇 |
2023年 | 270篇 |
2022年 | 543篇 |
2021年 | 863篇 |
2020年 | 626篇 |
2019年 | 798篇 |
2018年 | 662篇 |
2017年 | 541篇 |
2016年 | 710篇 |
2015年 | 1046篇 |
2014年 | 1225篇 |
2013年 | 1270篇 |
2012年 | 1502篇 |
2011年 | 1378篇 |
2010年 | 889篇 |
2009年 | 800篇 |
2008年 | 916篇 |
2007年 | 810篇 |
2006年 | 743篇 |
2005年 | 657篇 |
2004年 | 589篇 |
2003年 | 599篇 |
2002年 | 515篇 |
2001年 | 298篇 |
2000年 | 247篇 |
1999年 | 191篇 |
1998年 | 123篇 |
1997年 | 106篇 |
1996年 | 94篇 |
1995年 | 63篇 |
1994年 | 97篇 |
1993年 | 53篇 |
1992年 | 53篇 |
1991年 | 39篇 |
1990年 | 40篇 |
1989年 | 33篇 |
1988年 | 30篇 |
1987年 | 22篇 |
1986年 | 18篇 |
1985年 | 32篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 3篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1961年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Michael S. Dahabieh Fan Huang Christophe Goncalves Raúl Ernesto Flores Gonzlez Sathyen Prabhu Alicia Bolt Erminia Di Pietro Elie Khoury John Heath Zi Yi Xu Joelle Rmy-Sarrazin Koren K. Mann Alexandre Orthwein Franois-Michel Boisvert Nancy Braverman Wilson H. Miller Sonia V. del Rincn 《Autophagy》2022,18(3):540
993.
Cailian Fan Sui Liang Mengnan Ye Wanjun Cai Miao Chen Yunlong Hou Jun Guo Yi Dai 《Journal of cellular and molecular medicine》2022,26(9):2607
Pathological cardiac hypertrophy is the most important risk factor for developing chronic heart failure. Therefore, the discovery of novel agents for treating pathological cardiac hypertrophy remains urgent. In the present study, we examined the therapeutic effect and mechanism of periplocymarin (PM)‐mediated protection against pathological cardiac hypertrophy using angiotensinII (AngII)‐stimulated cardiac hypertrophy in H9c2 cells and transverse aortic constriction (TAC)‐induced cardiac hypertrophy in mice. In vitro, PM treatment significantly reduced the surface area of H9c2 cells and expressions of hypertrophy‐related proteins. Meanwhile, PM markedly down‐regulated AngII‐induced translocation of p‐STAT3 into the nuclei and enhanced the phosphorylation levels of JAK2 and STAT3 proteins. The STAT3 specific inhibitor S3I‐201 or siRNA‐mediated depleted expression could alleviate AngII‐induced cardiac hypertrophy in H9c2 cells following PM treatment; however, PM failed to reduce the expressions of hypertrophy‐related proteins and phosphorylated STAT3 in STAT3‐overexpressing cells, indicating that PM protected against AngII‐induced cardiac hypertrophy by modulating STAT3 signalling. In vivo, PM reversed TAC‐induced cardiac hypertrophy, as determined by down‐regulating ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL) and expressions of hypertrophy‐related proteins accompanied by the inhibition of the JAK2/STAT3 pathway. These results revealed that PM could effectively protect the cardiac structure and function in experimental models of pathological cardiac hypertrophy by inhibiting the JAK2/STAT3 signalling pathway. PM is expected to be a potential lead compound of the novel agents for treating pathological cardiac hypertrophy. 相似文献
994.
995.
Markus Albert Anna K. Jehle Martin Lipschis Katharina Mueller Yi Zeng Georg Felix 《European journal of cell biology》2010,89(2-3):200-207
In this review we focus on pattern recognition receptors in plants that detect extracellular signals indicative for pathogen attack and injury. We start out with a discussion on FLS2, which binds and responds to bacterial flagellin, and then concentrate on ligand–receptor interactions as initial steps in the molecular receptor activation process. Comparison with other receptor kinases, whether involved in plant immunity or regulation of other cellular programs, might indicate common principles of receptor activation. 相似文献
996.
Walters RW Yi SM Keshavjee S Brown KE Welsh MJ Chiorini JA Zabner J 《The Journal of biological chemistry》2001,276(23):20610-20616
Recombinant adeno-associated viruses (AAV) are promising gene therapy vectors. Whereas AAV serotype 2-mediated gene transfer to muscle has partially replaced factor IX deficiency in hemophilia patients, its ability to mediate gene transfer to the lungs for cystic fibrosis is hindered by lack of apical receptors. However, AAV serotype 5 infects human airway epithelia from the lumenal surface. We found that in contrast to AAV2, the apical membrane of airway epithelia contains abundant high affinity receptors for AAV5. Binding and gene transfer with AAV5 was abolished by genetic or enzymatic removal of sialic acid from the cell surface. Furthermore, binding and gene transfer to airway epithelia was competed by lectins that specifically bind 2,3-linked sialic acid. These observations suggest that 2,3-linked sialic acid is either a receptor for AAV5 or it is a necessary component of a receptor complex. Further elucidation of the receptor for this virus should enhance understanding of parvovirus biology and expand the therapeutic targets for AAV vectors. 相似文献
997.
Southall MD Isenberg JS Nakshatri H Yi Q Pei Y Spandau DF Travers JB 《The Journal of biological chemistry》2001,276(49):45548-45554
998.
Kimura T Tani S Matsumoto Yi Y Takeda T 《The Journal of biological chemistry》2001,276(45):41576-41579
It has been suggested that some factor present in human plasma binds to Shiga toxin 2 (Stx2) and neutralizes it in vitro (Bitzan, M., Klemt, M., Steffens, R., and Muller-Wiefel, D. E. (1993) Infection 21, 140-145). This factor does not exist in other species (Caprioli, A., Luzzi, I., Seganti, L., Marchetti, M., Karmali, M., Clarke, I., and Boyd, B. (1994) Recent Adv. VTEC Infect. 353-356). Because analysis of this factor is important to understanding the pathology induced by Shiga toxin-producing Escherichia coli, we purified this factor from human plasma and identified it. Purification was carried out by serially subjecting human plasma to Con A-Sepharose, DEAE-Sepharose, hydroxyapatite, and gel-filtration high performance liquid chromatography (HPLC), using Stx2-neutralizing activity as the indicator. The gel-filtration HPLC fraction yielded a single band on SDS-polyacrylamide gel electrophoresis. Twenty N-terminal amino acid residues of this fraction were analyzed and found to correspond perfectly to human serum amyloid P component (HuSAP). Because commercially available HuSAP also showed Stx2 binding and neutralizing activity, we identified this factor as HuSAP. 相似文献
999.
Homocysteine metabolism in children with Down syndrome: in vitro modulation 总被引:8,自引:0,他引:8 下载免费PDF全文
Pogribna M Melnyk S Pogribny I Chango A Yi P James SJ 《American journal of human genetics》2001,69(1):88-95
The gene for cystathionine beta-synthase (CBS) is located on chromosome 21 and is overexpressed in children with Down syndrome (DS), or trisomy 21. The dual purpose of the present study was to evaluate the impact of overexpression of the CBS gene on homocysteine metabolism in children with DS and to determine whether the supplementation of trisomy 21 lymphoblasts in vitro with selected nutrients would shift the genetically induced metabolic imbalance. Plasma samples were obtained from 42 children with karyotypically confirmed full trisomy 21 and from 36 normal siblings (mean age 7.4 years). Metabolites involved in homocysteine metabolism were measured and compared to those of normal siblings used as controls. Lymphocyte DNA methylation status was determined as a functional endpoint. The results indicated that plasma levels of homocysteine, methionine, S-adenosylhomocysteine, and S-adenosylmethionine were all significantly decreased in children with DS and that their lymphocyte DNA was hypermethylated relative to that in normal siblings. Plasma levels of cystathionine and cysteine were significantly increased, consistent with an increase in CBS activity. Plasma glutathione levels were significantly reduced in the children with DS and may reflect an increase in oxidative stress due to the overexpression of the superoxide dismutase gene, also located on chromosome 21. The addition of methionine, folinic acid, methyl-B(12), thymidine, or dimethylglycine to the cultured trisomy 21 lymphoblastoid cells improved the metabolic profile in vitro. The increased activity of CBS in children with DS significantly alters homocysteine metabolism such that the folate-dependent resynthesis of methionine is compromised. The decreased availability of homocysteine promotes the well-established "folate trap," creating a functional folate deficiency that may contribute to the metabolic pathology of this complex genetic disorder. 相似文献
1000.